Ursodeoxicholsyra
Ursodeoxicholsyra
Klass : 1
Visa all info
Skriv ut
Kontakta oss
Brites D, Rodrigues CM. Elevated levels of bile acids in colostrum of patients with cholestasis of pregnancy are decreased following ursodeoxycholic acid therapy [see comemnts]. J Hepatol. 1998;29:743-51.
Rudi J, Schönig T, Stremmel W. -Therapy with ursodeoxycholic acid in primary biliary cirrhosis in pregnancy-. Z Gastroenterol. 1996;34:188-91.
Vítek L, Zelenková M, Brůha R. Safe use of ursodeoxycholic acid in a breast-feeding patient with primary biliary cirrhosis. Dig Liver Dis. 2010;42:911-2.
Šimják P, Petr T, Kaslová B, Fejfar T, Hůlek P, Pařízek A et al. Ursodeoxycholic acid use in lactating female patients is associated with clinically negligible concentrations of this bile acid in breast milk. Sci Rep. 2022;12(1):19543.
Erol-Coskun H, Karagur N, Akyol F, et al. Ursodiol Use During Breastfeeding: A Case Report. Reprod Toxicol. 2018;80(59):159.
- Brites D, Rodrigues CM. Elevated levels of bile acids in colostrum of patients with cholestasis of pregnancy are decreased following ursodeoxycholic acid therapy [see comemnts]. J Hepatol. 1998;29:743-51.
- Rudi J, Schönig T, Stremmel W. -Therapy with ursodeoxycholic acid in primary biliary cirrhosis in pregnancy-. Z Gastroenterol. 1996;34:188-91.
- Vítek L, Zelenková M, Brůha R. Safe use of ursodeoxycholic acid in a breast-feeding patient with primary biliary cirrhosis. Dig Liver Dis. 2010;42:911-2.
- Šimják P, Petr T, Kaslová B, Fejfar T, Hůlek P, Pařízek A et al. Ursodeoxycholic acid use in lactating female patients is associated with clinically negligible concentrations of this bile acid in breast milk. Sci Rep. 2022;12(1):19543.
- Erol-Coskun H, Karagur N, Akyol F, et al. Ursodiol Use During Breastfeeding: A Case Report. Reprod Toxicol. 2018;80(59):159.
Innehållet senast uppdaterat 11/7/2024